D. E. Shaw & Co »

Urogen Pharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 78k 15.00
2023-09-30 $471k 34k 14.01

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma